Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,330,590
-
Share change
-
-1,034,902
-
Total reported value
-
$8,893,000
-
Price per share
-
$2.67
-
Number of holders
-
21
-
Value change
-
-$2,042,912
-
Number of buys
-
9
-
Number of sells
-
12
Institutional Holders of ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) as of Q2 2021
As of 30 Jun 2021,
ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,330,590 shares.
The largest 10 holders included
TPG Group Holdings (SBS) Advisors, Inc., EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, Alberta Investment Management Corp, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Janney Montgomery Scott LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.